The inclusion of NTRK-rearranged spindle cell neoplasms (excluding infantile fibrosarcoma that represent a distinct clinicopathologic entity molecularly characterized by the presence of NTRK3-ETV6 fusion gene), within the category of tumours of uncertain differentiation represents one of the most relevant innovations. The gene discussed is ETV6; the disease is fibrosarcoma.